Your session is about to expire
← Back to Search
Procedure
Minimally Invasive Radioguided Parathyroidectomy (MIRP Trial)
N/A
Waitlist Available
Led By Michael J Flynn, M.D.
Research Sponsored by University of Louisville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* All patients with biochemical evidence of primary hyperparathyroidis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
The main purpose of this research study is to evaluate the effectiveness of a minimally invasive surgical approach to removing parathyroid gland(s). The researchers are also interested in analyzing abnormal parathyroid tissue for changes in genes and proteins that may contribute to overactive parathyroid gland(s).
Eligible Conditions
- Primary Hyperparathyroidism
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Parathyroid surgeryExperimental Treatment1 Intervention
Database of patients who have undergone minimally invasive radioguided parathyroidectomy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Minimally invasive radioguided parathyroidectomy
1998
N/A
~860
Find a Location
Who is running the clinical trial?
University of LouisvilleLead Sponsor
348 Previous Clinical Trials
76,845 Total Patients Enrolled
Norton HealthcareOTHER
16 Previous Clinical Trials
2,005 Total Patients Enrolled
Jewish Hospital and St. Mary's HealthcareOTHER
4 Previous Clinical Trials
93 Total Patients Enrolled
Michael J Flynn, M.D.Principal InvestigatorUniversity of Louisville